First Group Consent Decree and Final Judgment
Hytrin Antitrust Case
SETTLEMENT, CONSUMER REFUNDS IN HYTRIN ANTITRUST CASE
Hytrin, which is used in the treatment of hypertension and enlarged prostate, is manufactured by Abbott Laboratories, and the generic version (called "terazosin") is produced by Geneva Pharmaceuticals. According to a federal lawsuit, Abbott wrongfully paid Geneva to delay introduction of its generic version of Hytrin and took other steps to delay competition from lower-priced generic versions of its product. This illegal activity harmed consumers.
Under the settlement agreement, which is still subject to final court approval, Abbott and Geneva would provide $28.7 million for consumers and third-party payers in Illinois and 17 other states. The most direct way for consumers to obtain claims forms is through the settlement website, http://www.terazosinlitigation.com. Claims forms must be mailed to the settlement administrator no later than July 15, 2005.
The settlement will benefit consumers who purchased terazosin products between October 15, 1995, and March 7, 2005, and amounts of refunds will depend on how many consumers file claims against the settlement fund. The settlement applies to consumers and third-party payers in Alabama, California, Florida, Illinois, Kansas, Maine, Michigan, Minnesota, Mississippi, Nevada, New Mexico, New York, North Carolina, North Dakota, South Dakota, Tennessee, West Virginia and Wisconsin.
Between 1999 and 2001, a number of consumers filed lawsuits against Abbott and Geneva. The cases were consolidated into a single lawsuit in federal court in the Southern District of Florida. After conducting their own investigations, the states of Florida, Kansas and Colorado filed their own lawsuit in the same court. The settlement establishes a separate $2 million fund to reimburse state agency claims and litigation costs incurred by Florida, Kansas and Colorado.
Consumers may obtain a claims form from the settlement website, http://www.terazosinlitigation.com; by calling the settlement administrator toll-free at 1-877-886-0283; or by writing to the settlement administrator at:
In re Terazosin Hydrochloride Antitrust Litigation
If you are an Illinois resident and purchased food or household products containing preservatives know as Sorbates during the period 1979 through 1997, you are a member of the class represented in this case. If you do not want to remain in that class, you must opt out of the case by October 18, 2004. If you want to remain in the class and comment on the proposed settlement, you must notify the court by December 15, 2004. If you wish to take either action, or just want more information about this case, please review the documents below:
The following pdf documents are also available to provide additional information about this case:
Attorney General Lisa Madigan is pleased to announce the availability of grant funds from the Salton Anti-Trust Settlement to serve the interests of those persons affected by the increased prices of George Foreman grills. The grant funds were available to Illinois not-for-profit organizations for new health and/or nutrition related programs.
The application deadline was February 2, 2004.